067630 — HLB Life Science Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapSucker Stock

Market Cap
KR₩899bn
Enterprise Value
KR₩912bn
Revenue
KR₩98bn

Annual balance sheet for HLB Life Science Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	175,756	158,034	139,961	128,271	77,662
Net Total Accounts Receivable
Net Total Receivables	40,735	19,821	14,464	17,301	14,646
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	223,667	181,329	156,822	160,776	147,043
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	23,056	22,935	22,081	92,089	72,918
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	404,935	327,197	270,800	411,790	423,500
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	39,845	17,865	13,536	26,785	135,457
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	71,112	40,016	24,611	177,065	192,704
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	333,823	287,181	246,189	234,725	230,797
Total Liabilities & Shareholders' Equity	404,935	327,197	270,800	411,790	423,500
Total Common Shares Outstanding